Riccardo Valdez

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Characterization of a new SARS-CoV-2 variant that emerged in Brazil”.

Characterization of a new SARS-CoV-2 variant that emerged in Brazil

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2106535118

N/A

0DataRank · unranked

87 citations

Peter Halfmann, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, S. Chiba, Tokiko Watanabe +54 more

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies

Microbiology Spectrum(2021)10.1128/spectrum.00087-21

N/A

0DataRank · unranked

21 citations

Carmen Gherasim, Kelly J. O’Shea, David M. Manthei, Jesse Chen, Cristyn Zettel +8 more

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Cell(2022)10.1016/j.cell.2022.12.018

N/A

0DataRank · unranked

948 citations

Sho Iketani, Zhiteng Li, Liyuan Liu, Yicheng Guo, Yiming Huang +12 more

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1

N/A

0DataRank · unranked

293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant

Science Translational Medicine(2022)10.1126/scitranslmed.abm4908

N/A

0DataRank · unranked

38 citations

Makoto Kuroda, Tammy Armbrust, James Theiler, Ariane Balaram, Gage K. Moreno +25 more

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.23.517532

N/A

0DataRank · unranked

103 citations

Sho Iketani, Zhiteng Li, Liyuan Liu, Yicheng Guo, Yiming Huang +12 more

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster

New England Journal of Medicine(2023)10.1056/nejmc2213907

N/A

0DataRank · unranked

212 citations

Anthony Bowen, Riccardo Valdez, Carmen Gherasim, Aubree Gordon, Lihong Liu +2 more

Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101258

N/A

0DataRank · unranked

76 citations

Yicheng Guo, Anthony Raymond Tam, Riccardo Valdez, Aubree Gordon, Lihong Liu +2 more

SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00181-0

N/A

0DataRank · unranked

55 citations

Anthony Bowen, Anthony Raymond Tam, Riccardo Valdez, Emily Stoneman, Ian A. Mellis +4 more

Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

iScience(2023)10.1016/j.isci.2023.108254

N/A

0DataRank · unranked

28 citations

Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu +8 more

SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster

The Lancet(2023)10.1016/s0140-6736(23)02278-x

N/A

0DataRank · unranked

16 citations

Anthony Bowen, Jerren Ho, Richard M. Zhang, Riccardo Valdez, Emily Stoneman +4 more

Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing

Frontiers in Immunology(2023)10.3389/fimmu.2023.1055429

N/A

0DataRank · unranked

9 citations

Charles F. Schuler, Jesse Chen, Jonathan P. Troost, Pamela T. Wong, Kelsea Chen +8 more

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.26.568730

N/A

0DataRank · unranked

43 citations

Yicheng Guo, Anthony Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim +4 more

Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.24.559214

N/A

0DataRank · unranked

11 citations

Yicheng Guo, Liyuan Liu, Logan T. Schwanz, Zhiteng Li, Jerren Ho +12 more

Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.22.533805

N/A

0DataRank · unranked

7 citations

Zhiteng Li, Yicheng Guo, Ian A. Mellis, Sho Iketani, Michael Liu +8 more

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1

Cell Host & Microbe(2024)10.1016/j.chom.2024.01.014

N/A

0DataRank · unranked

178 citations

Yicheng Guo, Anthony Bowen, Ian A. Mellis, Riccardo Valdez, Carmen Gherasim +4 more

Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages

Emerging Microbes & Infections(2024)10.1080/22221751.2024.2402880

N/A

0DataRank · unranked

57 citations

Ian A. Mellis, Jerren Ho, Anthony Bowen, Theresa Kowalski-Dobson, Riccardo Valdez +9 more

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101701

N/A

0DataRank · unranked

11 citations

Ian A. Mellis, Yicheng Guo, Carmen Gherasim, Riccardo Valdez, Aubree Gordon +3 more

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1

Emerging Microbes & Infections(2024)10.1080/22221751.2024.2359004

N/A

0DataRank · unranked

6 citations

Yicheng Guo, Logan T. Schwanz, Ian A. Mellis, Yiwei Sun, Yiming Qu +8 more

Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC

Cell Reports(2025)10.1016/j.celrep.2025.115543

N/A

0DataRank · unranked

41 citations

Yicheng Guo, Ian A. Mellis, Madeline Wu, Hiroshi Mohri, Carmen Gherasim +6 more

KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00058-1

N/A

0DataRank · unranked

21 citations

Ian A. Mellis, Madeline Wu, Anthony Bowen, Carmen Gherasim, Riccardo Valdez +7 more

Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections

Nature Immunology(2025)10.1038/s41590-025-02162-2

N/A

0DataRank · unranked

3 citations

Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang +24 more

Do Existing COVID-19 Vaccines Need to Be Updated in 2025?

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.02.651777

N/A

0DataRank · unranked

5 citations

Madeline Wu, Qian Wang, Anthony Bowen, Carmen Gherasim, Riccardo Valdez +7 more